Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing)
Code effective Jan 01, 2023
HCPCS Section
Medical services
M1194 is a valid 2026 HCPCS code meaning Documentation of medical reason(s) surgical pathology reports did not contain impression or conclusion of or recommendation for testing of mmr by immunohistochemistry, msi by dna-based testing status, or both tests were not included (e.g., patient will not be treated with checkpoint inhibitor therapy, no residual carcinoma is present in the sample [tissue exhausted or status post neoadjuvant treatment], insufficient tumor for testing) or (Med rsn no imp/con mmr/msi) for short. HCPCS M1194 has been effective since 01/01/2023 and applies to Medical care.
|
HCPCS Level II Code Section M - Medical services |
|
| HCPCS Code | M1194 |
|---|---|
| Description |
Long description:
Short description: |
| HCPCS Pricing indicator |
00 - Physician Fee Schedule And Non-Physician Practitioners - Service not separately priced by part B (e.g., services not covered, bundled, used by Part A only, etc.)
|
| Multiple pricing indicator |
9 - Not applicable as HCPCS not priced separately by part B or value is not established
|
| Coverage code | C - Carrier judgment |
| BETOS2 code | Z2 - Undefined codes |
| HCPCS Action code | N - No maintenance for this code |
| Type of service | 1 - Medical care |
| Effective date | Effective Jan 01, 2023 |
| Date added | Added Jan 01, 2023 |
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”
HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026
CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.